| |
| |
|
| Insider
Information: |
Dobmeier Eric |
| Relationship: |
President, CEO, Director |
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
730,812 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$28,069,465 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
730,812 |
|
|
| Total
Value |
$28,069,465 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
13
|
3
|
|
Stock
price went up :
|
7
|
3
|
| Stock
price went down : |
6
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.2
|
3.0
|
| Percentage
Gain/Loss : |
 17.0%
|
198.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
Chief Operating Officer |
2017-12-04 |
119,860 |
2004-05-05 |
0 |
Premium* |
|
|
Stemline Therapeutics Inc |
STML |
Director |
2017-06-19 |
27,963 |
|
0 |
Premium* |
|
|
Atara Biotherapeutics, Inc. |
ATRA |
|
2023-11-10 |
563,325 |
2015-12-16 |
0 |
Premium* |
|
|
Aravive Inc |
ARAV |
Director |
2017-12-20 |
18,160 |
2017-05-25 |
0 |
Premium* |
|
|
Adaptive Biotechnologies Corp |
ADPT |
Director |
2021-02-14 |
1,504 |
2019-12-26 |
0 |
Premium* |
|
|
Chinook Therapeutics Inc |
KDNY |
President, CEO, Director |
2023-08-11 |
0 |
2020-10-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
177 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2012-02-28 |
4 |
OE |
$10.20 |
$471,570 |
D/D |
46,000 |
99,844 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2012-04-25 |
4 |
OE |
$10.20 |
$255,957 |
D/D |
25,000 |
78,708 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2012-12-17 |
4 |
OE |
$10.20 |
$681,573 |
D/D |
62,418 |
163,829 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2012-06-18 |
4 |
OE |
$10.29 |
$257,250 |
D/D |
25,000 |
93,073 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2012-10-15 |
4 |
OE |
$10.29 |
$257,250 |
D/D |
25,000 |
94,352 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2012-11-13 |
4 |
OE |
$10.29 |
$255,305 |
D/D |
24,811 |
126,222 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2013-01-04 |
4 |
OE |
$11.09 |
$665,400 |
D/D |
60,000 |
173,829 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2007-09-19 |
4 |
S |
$11.50 |
$512,167 |
D/D |
(44,400) |
3,798 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2007-09-20 |
4 |
S |
$11.50 |
$81,727 |
D/D |
(7,100) |
3,798 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2008-09-26 |
4 |
S |
$11.53 |
$281,575 |
D/D |
(24,427) |
9,000 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2007-09-20 |
4 |
S |
$11.57 |
$192,261 |
D/D |
(16,500) |
3,798 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2007-09-19 |
4 |
S |
$11.60 |
$128,384 |
D/D |
(11,000) |
3,798 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2007-09-20 |
4 |
S |
$11.72 |
$225,367 |
D/D |
(19,100) |
3,798 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2021-08-18 |
4 |
B |
$11.74 |
$82,163 |
D/D |
7,000 |
104,837 |
2.81 |
% |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2007-09-20 |
4 |
S |
$11.87 |
$22,604 |
D/D |
(1,900) |
3,798 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2013-03-06 |
4 |
OE |
$12.00 |
$600,000 |
D/D |
50,000 |
172,948 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2013-03-11 |
4 |
OE |
$12.00 |
$605,671 |
D/D |
50,000 |
137,504 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2013-09-03 |
4 |
OE |
$12.00 |
$905,685 |
D/D |
68,223 |
160,317 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2014-08-27 |
4 |
OE |
$12.00 |
$99,996 |
D/D |
8,333 |
99,765 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2016-09-14 |
4 |
OE |
$12.00 |
$275,016 |
D/D |
22,918 |
88,067 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2021-08-19 |
4 |
B |
$12.00 |
$36,000 |
D/D |
3,000 |
107,837 |
2.81 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2021-09-20 |
4 |
B |
$12.00 |
$24,000 |
D/D |
2,000 |
109,837 |
2.81 |
% |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2013-03-04 |
4 |
OE |
$12.16 |
$455,185 |
D/D |
37,433 |
160,381 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Operating Officer |
• – – |
2013-03-05 |
4 |
OE |
$12.16 |
$152,815 |
D/D |
12,567 |
135,515 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2008-09-16 |
4 |
S |
$12.25 |
$367,455 |
D/D |
(30,000) |
33,427 |
0 |
- |
|
177 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
